Abbott (NYSE:ABT) said today that it promoted the head of its medical device division, the healthcare giant’s largest segment, to be its new operations chief. In naming former medical devices VP Robert Ford as COO, Abbott said Ford oversaw the integration of St. Jude Medical and was instrumental in the debut of Abbott’s FreeStyle Libre […]
LuxCath eyes the atrial fibrillation market
One problem with using ablation to treat atrial fibrillation is determining when the resulting lesion is sufficient to block the electric signals underlying the arrhythmia. LuxCath thinks its OmniView catheter solves the dilemma by using an optical technology to assess metabolic activity in the ablated tissue, CEO Dr. Omar Amirana told MassDevice.com earlier this month […]
LuxCath heart device sees 1st use in treating arrhythmia, AFIB
LuxCath said today its catheter-based ablation device was used in its 1st procedure to treat arrhythmia patients, including patients with atrial fibrillation. The surgeries were led by Mount Sinai Hospital arrhythmia services director Dr. Vivek Reddy. LuxCath’s catheter-based ablation device can assess tissue contact, visualize lesions and detect lesion gaps in real time, the company […]
Survey: Heart docs say Edwards on track for solid heart valve growth | Wall Street Beat
Edwards Lifesciences (NYSE:EW) is on track for solid growth in the transcatheter aortic valve implant market, according to a survey of cardiologists conducted by Leerink Swann analysts.
